170 related articles for article (PubMed ID: 31577469)
1. Therapeutic approaches to cholinergic deficiency in Lewy body diseases.
Barrett MJ; Cloud LJ; Shah H; Holloway KL
Expert Rev Neurother; 2020 Jan; 20(1):41-53. PubMed ID: 31577469
[No Abstract] [Full Text] [Related]
2. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
3. Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson's disease dementia.
Gratwicke J; Oswal A; Akram H; Jahanshahi M; Hariz M; Zrinzo L; Foltynie T; Litvak V
Neuroimage; 2020 Nov; 221():117184. PubMed ID: 32711059
[TBL] [Abstract][Full Text] [Related]
4. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
J Neurosurg; 2019 Feb; 132(2):574-582. PubMed ID: 30797189
[TBL] [Abstract][Full Text] [Related]
5. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
[TBL] [Abstract][Full Text] [Related]
7. Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial.
Gratwicke J; Zrinzo L; Kahan J; Peters A; Brechany U; McNichol A; Beigi M; Akram H; Hyam J; Oswal A; Day B; Mancini L; Thornton J; Yousry T; Crutch SJ; Taylor JP; McKeith I; Rochester L; Schott JM; Limousin P; Burn D; Rossor MN; Hariz M; Jahanshahi M; Foltynie T
Brain Stimul; 2020; 13(4):1031-1039. PubMed ID: 32334074
[TBL] [Abstract][Full Text] [Related]
8. Cortical connectivity of the nucleus basalis of Meynert in Parkinson's disease and Lewy body dementias.
Oswal A; Gratwicke J; Akram H; Jahanshahi M; Zaborszky L; Brown P; Hariz M; Zrinzo L; Foltynie T; Litvak V
Brain; 2021 Apr; 144(3):781-788. PubMed ID: 33521808
[TBL] [Abstract][Full Text] [Related]
9. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.
Sakai K; Ikeda T; Ishida C; Komai K; Yamada M
Neuropathology; 2019 Aug; 39(4):319-323. PubMed ID: 31243794
[TBL] [Abstract][Full Text] [Related]
10. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
[TBL] [Abstract][Full Text] [Related]
11. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
Aarsland D; Mosimann UP; McKeith IG
J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):164-71. PubMed ID: 15312280
[TBL] [Abstract][Full Text] [Related]
12. EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer's disease.
Schumacher J; Thomas AJ; Peraza LR; Firbank M; Cromarty R; Hamilton CA; Donaghy PC; O'Brien JT; Taylor JP
Alzheimers Res Ther; 2020 Apr; 12(1):46. PubMed ID: 32321573
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.
Ballard C; Aarsland D; Francis P; Corbett A
Drugs Aging; 2013 Aug; 30(8):603-11. PubMed ID: 23681401
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
[TBL] [Abstract][Full Text] [Related]
16. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
17. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease.
Burn DJ; McKeith IG
Mov Disord; 2003 Sep; 18 Suppl 6():S72-9. PubMed ID: 14502659
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies.
Camicioli R; Gauthier S
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S109-17. PubMed ID: 17469693
[TBL] [Abstract][Full Text] [Related]
19. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
[TBL] [Abstract][Full Text] [Related]
20. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
Duda JE
Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
